367
Participants
Start Date
October 20, 2023
Primary Completion Date
November 23, 2026
Study Completion Date
November 23, 2026
GSK4527226
GSK4527226 will be administered.
Placebo
Placebo will be administered.
GSK Investigational Site, Tau-Yuan
GSK Investigational Site, Tainan City
GSK Investigational Site, Kaohsiung City
GSK Investigational Site, Darlinghurst
GSK Investigational Site, Camperdown
GSK Investigational Site, Macquarie Park
GSK Investigational Site, Kogarah
GSK Investigational Site, Heidelberg
GSK Investigational Site, Gold Coast
GSK Investigational Site, Bergen
GSK Investigational Site, Nedlands
GSK Investigational Site, Staten Island
GSK Investigational Site, Genova
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Turku
GSK Investigational Site, Monza
GSK Investigational Site, Malmo
GSK Investigational Site, Fairfax
GSK Investigational Site, Brescia
GSK Investigational Site, Pavia
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Matthews
GSK Investigational Site, Madrid
GSK Investigational Site, Decatur
GSK Investigational Site, Pamplona
GSK Investigational Site, Toulouse
GSK Investigational Site, The Villages
GSK Investigational Site, The Villages
GSK Investigational Site, Lake Mary
GSK Investigational Site, Maitland
GSK Investigational Site, Orlando
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Lake Worth
GSK Investigational Site, CapaIstanbul
GSK Investigational Site, Stuart
GSK Investigational Site, Salamanca
GSK Investigational Site, Modena
GSK Investigational Site, Saint-Herblain
GSK Investigational Site, North Canton
GSK Investigational Site, Valencia
GSK Investigational Site, Münster
GSK Investigational Site, Getxo - Vizcaya
GSK Investigational Site, Cologne
GSK Investigational Site, Lille
GSK Investigational Site, Elk Grove Village
GSK Investigational Site, Chesterfield
GSK Investigational Site, Erbach im Odenwald
GSK Investigational Site, Strasbourg
GSK Investigational Site, Villeurbanne
GSK Investigational Site, Bron
GSK Investigational Site, Kuopio
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Paris
GSK Investigational Site, Paris
GSK Investigational Site, Houston
GSK Investigational Site, München
GSK Investigational Site, CefalU PA
GSK Investigational Site, Oulu
GSK Investigational Site, San Diego
GSK Investigational Site, Junggu
GSK Investigational Site, Toms River
GSK Investigational Site, Portland
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Ciudad Autonoma de Buenos Aire
GSK Investigational Site, Ciudad Autonoma de Bueno
GSK Investigational Site, Melbourne
GSK Investigational Site, Stavanger
GSK Investigational Site, Stockholm
GSK Investigational Site, Ottawa
GSK Investigational Site, Peterborough
GSK Investigational Site, Toronto
GSK Investigational Site, Greenfield Park
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Helsinki
GSK Investigational Site, Nice
GSK Investigational Site, Perugia
GSK Investigational Site, 's-Hertogenbosch
GSK Investigational Site, Amsterdam
GSK Investigational Site, Zwolle
GSK Investigational Site, Oslo
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Terrassa - Barcelona
GSK Investigational Site, Gothenburg
GSK Investigational Site, Ankara
GSK Investigational Site, Birmingham
GSK Investigational Site, Bristol
GSK Investigational Site, Glasgow
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, London
Lead Sponsor
Collaborators (1)
Alector Inc.
INDUSTRY
GlaxoSmithKline
INDUSTRY